Hearing loss among patients on treatment for drug-resistant tuberculosis in Uganda

Hearing loss among patients on treatment for drug-resistant tuberculosis in Uganda

Introduction: Second-line injectable therapy using aminoglycosides (AG) like kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. We aimed to determine the incidence and predictors of hearing loss among patients with drug resistant tuberculosis (DR-TB) who received AG. M...

Full description

Bibliographic Details
Main Authors: Lodiong Jackson Dumo Lodiong, Timbine Amos, Boniface Amanee Elias Lumori, Edwin Nuwagira
Format: Article
Language:English
Published: Health and Social Sciences Research Institute - South Sudan (HSSRI-SS) 2021-08-01
Series:South Sudan Medical Journal
Subjects:
drug resistant tuberculosis
hearing loss
uganda
aminoglycosides
Online Access:http://www.southsudanmedicaljournal.com/archive/august-2021/hearing-loss-among-patients-on-treatment-for-drug-resistant-tuberculosis-in-uganda.html

Internet

http://www.southsudanmedicaljournal.com/archive/august-2021/hearing-loss-among-patients-on-treatment-for-drug-resistant-tuberculosis-in-uganda.html

Similar Items